Immunogenicity and Safety of the Spikevax (R) (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency-MedSci.cn

Immunogenicity and Safety of the Spikevax (R) (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency

Kralickova, P; Jankovicova, K; Sejkorova, I; Soucek, O; Koprivova, K; Drahosova, M; Andrys, C; Krejsek, J

Kralickova, P (通讯作者)，Univ Hosp Hradec Kralove, Inst Clin Immunol & Allergy, Hradec Kralove, Czech Republic.;Kralickova, P (通讯作者)，Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic.

Abstract

Introduction: Reports on the immunogenicity and efficacy of the Spikevax (R) vaccine against SARS-CoV-2 in immunodeficient patients are still scarce. ......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Immunogenicity and Safety of the Spikevax (R) (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency

科室

工具

服务